This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Solow, B. T. Articles by Jarett, L. Search for Related Content PubMed PubMed Citation Articles by Solow, B. T. Articles by Jarett, L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB L-TYROSINE

Differential Modulation of the Tyrosine Phosphorylation State of the Insulin Receptor by IRS (Insulin Receptor Subunit) Proteins

Department of Pathology and Laboratory Medicine (B.T.S., S.H., J.A.S., L.J.) University of Pennsylvania School of Medicine Philadelphia, Pennsylvania 19104
Dorrance H. Hamilton Research Laboratories (B.J.G.) Division of Endocrinology, Diabetes and Metabolic Diseases Department of Medicine Jefferson Medical College of Thomas Jefferson University Philadelphia, Pennsylvania 19107
Joslin Diabetes Center (M.F.W.) Boston, Massachusetts 02215

In response to insulin, tyrosine kinase activity of the insulin receptor is stimulated, leading to autophosphorylation and tyrosine phosphorylation of proteins including insulin receptor subunit (IRS)-1, IRS-2, and Shc. Phosphorylation of these proteins leads to activation of downstream events that mediate insulin action. Insulin receptor kinase activity is requisite for the biological effects of insulin, and understanding regulation of insulin receptor phosphorylation and kinase activity is essential to understanding insulin action. Receptor tyrosine kinase activity may be altered by direct changes in tyrosine kinase activity, itself, or by dephosphorylation of the insulin receptor by protein-tyrosine phosphatases. After 1 min of insulin stimulation, the insulin receptor was tyrosine phosphorylated 8-fold more and Shc was phosphorylated 50% less in 32D cells containing both IRS-1 and insulin receptors (32D/IR+IRS-1) than in 32D cells containing only insulin receptors (32D/IR), insulin receptors and IRS-2 (32D/IR+IRS-2), or insulin receptors and a form of IRS-1 that cannot be phosphorylated on tyrosine residues (32D/IR+IRS-1^F18). Therefore, IRS-1 and IRS-2 appeared to have different effects on insulin receptor phosphorylation and downstream signaling. Preincubation of cells with pervanadate greatly decreased protein-tyrosine phosphatase activity in all four cell lines. After pervanadate treatment, tyrosine phosphorylation of insulin receptors in insulin-treated 32D/IR, 32D/IR+IRS-2, and 32D/IR+IRS-1^F18 cells was markedly increased, but pervanadate had no effect on insulin receptor phosphorylation in 32D/IR+IRS-1 cells. The presence of tyrosine-phosphorylated IRS-1 appears to increase insulin receptor tyrosine phosphorylation and potentially tyrosine kinase activity via inhibition of protein-tyrosine phosphatase(s). This effect of IRS-1 on insulin receptor phosphorylation is unique to IRS-1, as IRS-2 had no effect on insulin receptor tyrosine phosphorylation. Therefore, IRS-1 and IRS-2 appear to function differently in their effects on signaling downstream of the insulin receptor. IRS-1 may play a major role in regulating insulin receptor phosphorylation and enhancing downstream signaling after insulin stimulation.

This article has been cited by other articles:

				H. Basciano, A. Miller, C. Baker, M. Naples, and K. Adeli LXR{alpha} activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins Am J Physiol Gastrointest Liver Physiol, August 1, 2009; 297(2): G323 - G332. [Abstract] [Full Text] [PDF]

				D. R. Johnson, J. C. O'Connor, R. Dantzer, and G. G. Freund Inhibition of vagally mediated immune-to-brain signaling by vanadyl sulfate speeds recovery from sickness PNAS, October 18, 2005; 102(42): 15184 - 15189. [Abstract] [Full Text] [PDF]

				C. Huang, A. C. P. Thirone, X. Huang, and A. Klip Differential Contribution of Insulin Receptor Substrates 1 Versus 2 to Insulin Signaling and Glucose Uptake in L6 Myotubes J. Biol. Chem., May 13, 2005; 280(19): 19426 - 19435. [Abstract] [Full Text] [PDF]

				A. Suryawan, H. V. Nguyen, R. A. Orellana, J. A. Bush, and T. A. Davis Insulin/Insulin-Like Growth Factor-I Hybrid Receptor Abundance Decreases with Development in Suckling Pigs J. Nutr., September 1, 2003; 133(9): 2783 - 2787. [Abstract] [Full Text] [PDF]

				R. N. Hasan, S. Phukan, and S. Harada Differential Regulation of Early Growth Response Gene-1 Expression by Insulin and Glucose in Vascular Endothelial Cells Arterioscler Thromb Vasc Biol, June 1, 2003; 23(6): 988 - 993. [Abstract] [Full Text] [PDF]

				A. Suryawan, H. V. Nguyen, J. A. Bush, and T. A. Davis Developmental changes in the feeding-induced activation of the insulin-signaling pathway in neonatal pigs Am J Physiol Endocrinol Metab, November 1, 2001; 281(5): E908 - E915. [Abstract] [Full Text] [PDF]

				R. M. K. Poltilove, A. R. Jacobs, C. R. Haft, P. Xu, and S. I. Taylor Characterization of Drosophila Insulin Receptor Substrate J. Biol. Chem., July 21, 2000; 275(30): 23346 - 23354. [Abstract] [Full Text] [PDF]